Elevar Therapeutics Overview
- Year Founded
-
2005

- Status
-
Acquired/Merged
- Latest Deal Type
-
Debt - PPP
Elevar Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to elevate treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. The company is engaged in developing two proprietary drug candidates that have demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with the potential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent, enabling patients to get a new way to treat disease.
Contact Information
Website
www.elevartherapeutics.com(Operating Subsidiary)
Corporate Office
- One Bridge Plaza North
- Suite 850
- Fort Lee, NJ 07024
- United States
Corporate Office
- One Bridge Plaza North
- Suite 850
- Fort Lee, NJ 07024
- United States
Elevar Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
4. Merger/Acquisition | 18-Oct-2019 | Completed | Generating Revenue | |||
3. Later Stage VC | 09-May-2019 | Completed | Generating Revenue | |||
2. Later Stage VC | 31-Jul-2018 | $20M | $20M | Completed | Generating Revenue | |
1. Secondary Transaction - Private | 29-Aug-2014 | $2M | Completed | Generating Revenue |
Elevar Therapeutics Comparisons
Industry
Financing
Details
Elevar Therapeutics Competitors (3)
One of Elevar Therapeutics’s 3 competitors is AVEO Oncology, a Formerly VC-backed company based in Boston, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
AVEO Oncology | Formerly VC-backed | Boston, MA | ||||
Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
Celldex Therapeutics | Formerly VC-backed | Hampton, NJ |
Elevar Therapeutics Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Paratus Investment | PE/Buyout | Minority |
Elevar Therapeutics Investments & Acquisitions (3)
Elevar Therapeutics’s most recent deal was a Corporate Asset Purchase with Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) for . The deal was made on 25-Mar-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) | 25-Mar-2020 | Corporate Asset Purchase | Buildings and Property | ||
Joint Venture (Neopharma / Elevar Therapeutics) | 25-Oct-2019 | Merger/Acquisition | Distributors (Healthcare) | ||
LSK Global Pharma Services | 01-Jan-2001 | Merger/Acquisition | Drug Discovery |
Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
LSK Global Pharma Services | Seoul, South Korea | 2000 |
Elevar Therapeutics FAQs
-
When was Elevar Therapeutics founded?
Elevar Therapeutics was founded in 2005.
-
Where is Elevar Therapeutics headquartered?
Elevar Therapeutics is headquartered in Fort Lee, NJ.
-
What industry is Elevar Therapeutics in?
Elevar Therapeutics’s primary industry is Biotechnology.
-
Is Elevar Therapeutics a private or public company?
Elevar Therapeutics is a Private company.
-
What is Elevar Therapeutics’s current revenue?
The current revenue for Elevar Therapeutics is
. -
How much funding has Elevar Therapeutics raised over time?
Elevar Therapeutics has raised $40M.
-
Who are Elevar Therapeutics’s investors?
Paratus Investment has invested in Elevar Therapeutics.
-
Who are Elevar Therapeutics’s competitors?
AVEO Oncology, Inovio Pharmaceuticals, and Celldex Therapeutics are competitors of Elevar Therapeutics.
-
When was Elevar Therapeutics acquired?
Elevar Therapeutics was acquired on 15-Apr-2020.
-
Who acquired Elevar Therapeutics?
Elevar Therapeutics was acquired by HLB.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »